This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johnson, P Articles by Benchimol, S Search for Related Content PubMed PubMed Citation Articles by Johnson, P Articles by Benchimol, S

Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells.

Ontario Cancer Institute, University of Toronto, Canada.

ABSTRACT

Inactivation of the cellular p53 gene is a common feature of Friend virus-induced murine erythroleukemia cell lines and may represent a necessary step in the progression of this disease. As well, frequent loss or mutation of p53 alleles in diverse human tumors is consistent with the view of p53 as a tumor suppressor gene. To examine the significance of p53 gene inactivation in tumorigenesis, we have attempted to express transfected wild-type p53 in three p53-negative tumor cell lines: murine DP16-1 Friend erythroleukemia cells, human K562 cells, and SKOV-3 cells. We found that aberrant p53 proteins, which differ from wild-type p53 by a single amino acid substitution, were expressed stably in these cells, whereas wild-type p53 expression was not tolerated. The inability of p53-negative tumor cell lines to support long-term expression of wild-type p53 protein is consistent with the view that p53 is a tumor suppressor gene.

This article has been cited by other articles:

• Berube, C., Boucher, L.-M., Ma, W., Wakeham, A., Salmena, L., Hakem, R., Yeh, W.-C., Mak, T. W., Benchimol, S. (2005). Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc. Natl. Acad. Sci. USA 102: 14314-14320 [Abstract] [Full Text]  
• Li, D., Tian, Y., Ma, Y., Benjamin, T. (2004). p150Sal2 Is a p53-Independent Regulator of p21WAF1/CIP. Mol. Cell. Biol. 24: 3885-3893 [Abstract] [Full Text]  
• Cheung, K-J. Jr., Mitchell, D., Lin, P., Li, G. (2001). The Tumor Suppressor Candidate p33ING1 Mediates Repair of UV-Damaged DNA. Cancer Res. 61: 4974-4977 [Abstract] [Full Text]  
• Nutt, C. L., Noble, M., Chambers, A. F., Cairncross, J. G. (2000). Differential Expression of Drug Resistance Genes and Chemosensitivity in Glial Cell Lineages Correlate with Differential Response of Oligodendrogliomas and Astrocytomas to Chemotherapy. Cancer Res. 60: 4812-4818 [Abstract] [Full Text]  
• Tang, H.-y., Zhao, K., Pizzolato, J. F., Fonarev, M., Langer, J. C., Manfredi, J. J. (1998). Constitutive Expression of the Cyclin-dependent Kinase Inhibitor p21 Is Transcriptionally Regulated by the Tumor Suppressor Protein p53. J. Biol. Chem. 273: 29156-29163 [Abstract] [Full Text]  
• Hwang, J.-K., Lin, C.-T. (1997). Co-localization of Endogenous and Exogenous p53 Proteins in Nasopharyngeal Carcinoma Cells. J. Histochem. Cytochem. 45: 991-1004 [Abstract] [Full Text]  
• Ronca, F., Chan, S.-L., Yu, V. C. (1997). 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine Induces Apoptosis in Human Neuroblastoma Cells, SH-SY5Y, through a p53-dependent Pathway. J. Biol. Chem. 272: 4252-4260 [Abstract] [Full Text]  
• Harris, C. C., Hollstein, M. (1993). Clinical Implications of the p53 Tumor-Suppressor Gene. NEJM 329: 1318-1327 [Full Text]